VISION

INFORMATION FOR SPECIALISTS

MARIGOLD EXTRACT PLUS

Form:
250 mg tablet
Daily intake: 1 tablet with meal, 3 tablets per day

Active ingredients (daily intake):

Marigold flower 750 mg
   (extract 75 mg, Lutein 15 mg, Zeaxanthin 1.875 mg); 
Goji berry 1800 mg
   (extract 180 mg, Polysaccharides 108 mg);
Vitamins 
   Vitamin C 60 mg
  

 


Marigold flower

REPORTED BENEFITS OF INGREDIENTS:

LUTEIN and ZEAXANTHIN
are the primary carotenoids found in the eye.
Individuals in the top quintile (20%) of Lutein / Zeaxanthin consumption are 50% less likely to develop a cataract compared to individuals in the lower quintile of consumption.
Lutein and Zeaxanthin, like "natural sun glasses", are able to protect the eyes against radiation damage by acting as an optic filter and an antioxidant. Higher intake of Lutein and Zeaxanthin resulted in a 30-40% reduction in the amount of blue light reaching the eye, and represents a substantial protection against the type of damage that leads to macular degeneration.
Numerous studies shown direct connection between Lutein and Zeaxanthin intake and the risk for age-related macular degeneration (ARMD). Studies revealed that retinas of individuals with macular degeneration had substantially lower levels of Zeaxanthin and Lutein. Individuals in the top quintile (20%) of Lutein and Zeaxanthin intake were found to have an 82% lower risk of developing age-related macular degeneration compared to individuals in the bottom quintile.
It was found that higher levels of Lutein and Zeaxanthin in the diet were associated with lower rates of pigmentary abnormalities. The results of clinical trials conducted for 120-140 days were maintained for 40-50 days after discontinuing the supplementation.

Precautions / Warnings/ Contraindications / Pregnancy & Lactation / Drug Interactions / Herb and Supplements Interactions
-


Goji berry

Published studies have reported possible medicinal benefits of GOJI, especially due to its antioxidant properties, including potential benefits against cardiovascular and inflammatory diseases, vision-related diseases (such as age-related macular degeneration and glaucoma), having neuro-protective properties or as an anti-cancer and immuno-modulatory agent.

Precautions / Warnings/ Contraindications / Pregnancy & Lactation / Drug Interactions / Herb and Supplements Interactions

VITAMINS
VITAMIN C

VITAMIN C is known antioxidant, which is responsible in stabilizing free radicals. It has been studied to lower the development of cataracts.

External links:

LUTEIN, ZEAXANTHIN
Wikipedia, the free encyclopedia: http://en.wikipedia.org/wiki/Lutein
Wikipedia, the free encyclopedia: http://en.wikipedia.org/wiki/Zeaxanthin
U.S. National Library of Medicine National Institutes of Health: http://www.ncbi.nlm.nih.gov/pubmed/15640510
American Optometric Association: http://www.aoa.org/x11815.xml
Lutein Information Bureau: http://www.luteininfo.com/
Macular Degeneration Support: http://www.mdsupport.org

GOJI

Wikipedia, the free encyclopedia: http://en.wikipedia.org/wiki/Wolfberry
WordPress Admin: http://www.gojiberrieshealthbenefits.com/
PRLog, Free Press Release: http://www.prlog.org/10354929-goji-berries-health-benefits.html
LYCIUM FRUIT Food and Medicine by Subhuti Dharmananda, Ph.D., Director, Institute for Traditional Medicine, Portland, Oregon: http://www.itmonline.org/arts/lycium.htm
http://montana.plant-life.org/species/lyci_barba.htm
Flora of China: http://www.efloras.org/florataxon.aspx?flora_id=2&taxon_id=200020536

References:
1. Berendschot TT, Goldbohm RA, Klopping WA, van de Kraats J, van Norel J, van Norren D. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci. Oct2000;41(11):3322-6.
2. Richer S, Stiles W, Statkute L, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry. Apr2004;75(4):216-30.
3. Cooper DA, Eldridge AL, Peters JC. Dietary carotenoids and certain cancers, heart disease, and age-related macular degeneration: a review of recent research. Nutr Rev. Jul1999;57(7):201-14.
4. Yeum KJ, et al. Measurement of Carotenoids, Retinoids, and Tocopherols in Human Lenses. Invest Ophthalmol Vis Sci. Dec1995;36(13):2756-61.
5. Lyle BJ, et al. Antioxidant Intake and Risk of Incident Age-related Nuclear Cataracts in the Beaver Dam Eye Study. Am J Epidemiol. May1999;149(9):801-09.
6. Pauleikhoff D, van Kuijk FJ, Bird AC. Macular pigment and age-related macular degeneration. Ophthalmologe. Jun2001;98(6):511-9.
7. Nussbaum JJ, et al. Historic Perspectives. Macular Yellow Pigment. The First 200 Years. Retina. 1981;1(4):296-310.
8. Landrum JT, et al. A One Year Study of the Macular Pigment: The Effect of 140 Days of a Lutein Supplement. Exp Eye Res. Jul1997;65(1):57-62.
9. Hammond BR Jr, et al. Dietary Modification of Human Macular Pigment Density. Invest Ophthalmol Vis Sci. Aug1997;38(9):1795-801.
10. Mares-Perlman JA, Fisher AI, Klein R, Palta M, Block G, Millen AE, Wright JD. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. Am J Epidemiol. Mar2001;153(5):424-32.
11. Aleman TS, Duncan JL, Bieber ML, de Castro E, Marks DA, Gardner LM, et al. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome. Invest Ophthalmol Vis Sci. Jul2001;42(8):1873-81.
12. Dagnelie G, Zorge IS, McDonald TM. Lutein improves visual function in some patients with retinal degeneration: a pilot study via the Internet. Optometry. Mar2000;71(3):147-64.
13. Brown L, Rimm EB, Seddon JM, et al. A prospective study of carotenoid intake and risk of cataract extraction in US men. Am J Clin Nutr. Oct1999;70(4):517-24.
14. Lyle BJ, Mares-Perlman JA, Klein BE, et al. Antioxidant intake and risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study. Am J Epidemiol. May1999;149(9):801-9.
15. Moeller SM, Jacques PF, Blumberg JB. The potential role of dietary xanthophylls in cataract and age-related macular degeneration. J Am Coll Nutr. Oct2000;19(5 Suppl):522S-527S.
16. Mares-Perlman JA, Fisher AI, Klein R, Palta M, Block G, Millen AE, Wright JD. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. Am J Epidemiol. Mar2001;153(5):424-32.
17. Wu SJ, Ng LT, Lin CC (December 2004). "Antioxidant activities of some common ingredients of traditional chinese medicine, Angelica sinensis, Lycium barbarum and Poria cocos". Phytother Res 18 (12): 100812. doi:10.1002/ptr.1617. PMID 15742346.
18. Jia YX, Dong JW, Wu XX, Ma TM, Shi AY (June 1998). "[The effect of lycium barbarum polysaccharide on vascular tension in two-kidney, one clip model of hypertension]" (in Chinese). Sheng Li Xue Bao 50 (3): 30914. PMID 11324572.
19. Luo Q, Li Z, Huang X, Yan J, Zhang S, Cai YZ (July 2006). "Lycium barbarum polysaccharides: Protective effects against heat-induced damage of rat testes and H2O2-induced DNA damage in mouse testicular cells and beneficial effect on sexual behavior and reproductive function of hemicastrated rats". Life Sci. 79 (7): 61321. doi:10.1016/j.lfs.2006.02.012. PMID 16563441.
20. Cheng CY, Chung WY, Szeto YT, Benzie IF (January 2005). "Fasting plasma zeaxanthin response to Fructus barbarum L. (wolfberry; Kei Tze) in a food-based human supplementation trial". Br. J. Nutr. 93 (1): 12330. doi:10.1079/BJN20041284. PMID 15705234. http://journals.cambridge.org/abstract_S0007114505000188.
21. Chan HC, Chang RC, Koon-Ching Ip A, et al. (January 2007). "Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma". Exp. Neurol. 203 (1): 26973. doi:10.1016/j.expneurol.2006.05.031. PMID 17045262.
22. Yu MS, Leung SK, Lai SW, et al. (2005). "Neuroprotective effects of anti-aging oriental medicine Lycium barbarum against beta-amyloid peptide neurotoxicity". Exp. Gerontol. 40 (8-9): 71627. doi:10.1016/j.exger.2005.06.010. PMID 16139464.
23. a b Gan L, Hua Zhang S, Liang Yang X, Bi Xu H (April 2004). "Immunomodulation and antitumor activity by a polysaccharide-protein complex from Lycium barbarum". Int. Immunopharmacol. 4 (4): 5639. doi:10.1016/j.intimp.2004.01.023. PMID 15099534.
24. He YL, Ying Y, Xu YL, Su JF, Luo H, Wang HF (September 2005). "[Effects of Lycium barbarum polysaccharide on tumor microenvironment T-lymphocyte subsets and dendritic cells in H22-bearing mice"] (in Chinese). Zhong Xi Yi Jie He Xue Bao 3 (5): 3747. doi:10.3736/jcim20050511. PMID 16159572. http://www.jcimjournal.com/en/showAbstrPage.aspx?articleid=428.
25. Wang Qiang, et.al., Determination of polysaccharide contents in Fructus Lycii, Chinese Traditional and Herbal Drugs 1991; 22(2): 6768
26. Tian M and Wang M, Studies on extraction, isolation, and composition of Lycium barbarum polysaccharides, Journal of Traditional Chinese Herb Drugs, 2006 31(19): 16031607
27. Cao GW and Yang WG, Observation of the effects of LAK/IL-2 therapy combining with Lycium barbarum polysaccharides, China Journal of Oncology 1994; 16: 428431
28. Chang RC and So KF, Use of Anti-aging Herbal Medicine, Lycium barbarum, Against Aging-associated Diseases, Cellular and Molecular Neurobiology 2007

Copyright © 2017 Complete-Pharma.com. All Rights Reserved